Here are four key points:
1. The acquisition costs include $125 million up front and up to an additional $85 million over the next five years, which is contingent on financial performance.
2. Rotation Medical is the developer of an innovative tissue regeneration technology for shoulder rotator cuff repair. Smith & Nephew believes the system will compliment its current shoulder repair technologies portfolio.
3. Rotation Medical’s regeneration technology will be sold through Smith & Nephew’s sports medicine task force and the integrated Rotation Medical sales team.
4. The rotator cuff repair technology is approved for sale in the U.S., and Smith & Nephew filed for approval in Europe.
More articles on devices and implants:
FDA releases new guidance for 3-D printing medical devices: 5 things to know
Exactech receives $737M offer from TPG Capital to purchase the company: 3 notes
Global spinal fusion devices market to reach nearly $11B by 2025: 6 observations
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
